Knee replacement recovery study pulled before it began
NCT ID NCT06054750
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to test different regional anesthesia techniques to help people recover faster and go home sooner after total knee replacement. It planned to compare a standard pain injection with an added nerve block or continuous nerve block infusion. However, the study was withdrawn before enrolling any participants, so no data was collected.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Ropivacaine
- What this could lead to
- If successful, this could help design larger trials to improve recovery and enable earlier discharge after knee replacement surgery.
- What could go wrong
- The study was withdrawn before enrolling any participants, so no results are available. It was only a feasibility trial, not designed to prove effectiveness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Started
-
Jan 2026
- Finished
-
Mar 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * All adult patients presenting for a primary TKA. Exclusion Criteria: * Age \<18 years; * Body mass index ≥45 kg/m2; * Weight \<80 kg; * Deemed unsuitable for regional anesthesia; * Planned general anesthesia; * Hepatic insufficiency/Intolerance to acetaminophen; * Renal insufficiency (defined by estimated glomerular filtration rate \<60 mL/min/1.73 m2); * Chronic opioid use (individuals requiring the equivalent of 1 mg or more of intravenous morphine, or 3 mg or more of oral morphine per hour for greater than 1 month); * Allergy or intolerance to study medications (listed under 'Spinal and Adductor Canal Block') or trial medications listed in "Postoperative" section and "standard prescription" * Clinical Frailty Scale score ≥4;
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Arthroplasty, replacement, knee are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
St Joseph's Healthcare Hamilton
Hamilton, Ontario, L8N 4A6, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can robotic surgery personalize knee replacement?
- Custom knee guides put to the test in obese patients
- Can a shot of your own blood ease arthritic knees?
- 5,000 knee arthritis patients tracked to crack the treatment code
- Can a hydrogel injection ease knee arthritis pain?
- Weekly shot aims to melt away pounds in obesity fight